These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 7855535)

  • 21. [Blood transfusions and component therapy in clinical practice].
    Korolev SS
    Med Sestra; 1981 Nov; 40(11):41-7. PubMed ID: 6915347
    [No Abstract]   [Full Text] [Related]  

  • 22. [The status of blood component therapy in East Germany].
    Fünfhausen G
    Beitr Infusionsther; 1988; 21():354-6. PubMed ID: 2463009
    [No Abstract]   [Full Text] [Related]  

  • 23. Results of the SAnGUIS study in Belgium. A concerted action of the Commission of the European Communities IVth Medical and Health Research Programme. The Belgium SAnGUIS Study Group. Safe AND Good Use of blood In Surgery.
    Baele PL; De Bruyère M; Deneys V; Dupont E; Flament J; Lambermont M; Latinne D; Steensens L; Van Camp B; Waterloos H
    Acta Chir Belg; 1994; 94 Suppl():1-61. PubMed ID: 8209598
    [No Abstract]   [Full Text] [Related]  

  • 24. [Blood cell component transfusion].
    Amagi K
    Rinsho Ketsueki; 1983 May; 24(5):491-7. PubMed ID: 6350642
    [No Abstract]   [Full Text] [Related]  

  • 25. New trends in blood component therapy.
    Högman CF
    Haematologia (Budap); 1983; 16(1-4):23-38. PubMed ID: 6383964
    [No Abstract]   [Full Text] [Related]  

  • 26. Transfusion practice in massively bleeding patients: time for a change?
    Johansson PI; Hansen MB; Sørensen H
    Vox Sang; 2005 Aug; 89(2):92-6. PubMed ID: 16101690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of uncontrollable, life-threatening hemorrhage].
    Stensballe J; Lethagen S; Johansson PI
    Ugeskr Laeger; 2005 Jun; 167(25-31):2789-90. PubMed ID: 16014269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood groups and transfusions in pigs.
    Smith DM; Newhouse M; Naziruddin B; Kresie L
    Xenotransplantation; 2006 May; 13(3):186-94. PubMed ID: 16756561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The epidemiology of blood component transfusion in Catalonia, Northeastern Spain.
    Bosch MA; Contreras E; Madoz P; Ortiz P; Pereira A; Pujol MM;
    Transfusion; 2011 Jan; 51(1):105-16. PubMed ID: 20663112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Indications for labile blood products and the physiology of transfusion in surgery].
    Ozier Y; Mignon A; Rosencher N
    Transfus Clin Biol; 2005 Jun; 12(2):221-5. PubMed ID: 15950892
    [No Abstract]   [Full Text] [Related]  

  • 31. [The possibility of blood component therapy in Croatia (author's transl)].
    Grgicević D; Bozović I; Pende B
    Lijec Vjesn; 1981; 103(2-3):119-22. PubMed ID: 7311696
    [No Abstract]   [Full Text] [Related]  

  • 32. [A guide on the use of blood and blood components. A group for the study of immunohematology and hemotherapy].
    Med Clin (Barc); 1988 Dec; 91(19):747-9. PubMed ID: 3236921
    [No Abstract]   [Full Text] [Related]  

  • 33. [Erythrocyte and platelet transfusion].
    Subtil E
    Soins; 1979 Aug 5-20; 24(15-16):71-6. PubMed ID: 258519
    [No Abstract]   [Full Text] [Related]  

  • 34. Modern principles of blood transfusion therapy.
    Wallas CH; Panlilio AL; Jenkins DE
    J Tenn Med Assoc; 1978 Sep; 71(9):651-8. PubMed ID: 703308
    [No Abstract]   [Full Text] [Related]  

  • 35. [Blood component therapy program for surgical practice. Comment on the article by Glück, Dorothee, Kubenek and Ahnefeld: blood component therapy--a transfusion plan for consequent use of volume replacement, mass transfusion and in shock].
    Lange G; Wilms K
    Anaesthesiol Reanim; 1988; 13(3):183-8. PubMed ID: 3214515
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular basis of erythrocyte blood group antigens and applications in transfusion medicine.
    Storry JR
    Vox Sang; 2002 Aug; 83 Suppl 1():81-4. PubMed ID: 12617109
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic indications for platelets, plasma and plasma derivatives in the neonate.
    Kevy SV
    Mead Johnson Symp Perinat Dev Med; 1986; (28):55-60. PubMed ID: 3333267
    [No Abstract]   [Full Text] [Related]  

  • 38. Recommendations concerning the indications for the use of blood and blood products.
    Aust N Z J Surg; 1978 Apr; 48(2):230-2. PubMed ID: 280333
    [No Abstract]   [Full Text] [Related]  

  • 39. Administration of whole blood, packed red blood cells, and platelets using a multipurpose infusion pump.
    Strayer AH; Henry DW; Erenberg A; Leff RD
    Am J Hosp Pharm; 1991 Sep; 48(9):1970-2. PubMed ID: 1928143
    [No Abstract]   [Full Text] [Related]  

  • 40. [The immunological aspects of blood transfusion].
    Klimiashvili AD
    Med Sestra; 1991 Mar; 50(3):28-31. PubMed ID: 1870397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.